ISSN:
1432-0428
Keywords:
Glycosylated haemoglobin
;
artificial endocrine pancreas
;
continuous blood glucose monitoring
;
subcutaneous insulin treatment
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary In order to verify whether or not insulininduced blood glucose control can acutely lower glycosylated haemoglobin levels, HbAI (a+b+c) (HbAI) was measured in 11 diabetics before, during and after 3 days of treatment with an “artificial endocrine pancreas” (Biostator). Initially 5 patients were in fair glycaemic control (group A), while the other 6 showed poor control (group B). HbAI levels decreased significantly after 3 days in both groups A (from 9.6 ± 0.2% to 8.5 ± 0.3%, mean ± SEM, p 〈 0.05) and B (from 13.7 ± 0.2% to 12.6 ± 0.3%, p 〈 0.05). A further HbAI decrease was observed until day 60 following Biostator treatment, during which period glycaemic control inproved, as assessed by fasting and post-lunch plasma glucose values and daily glycosuria determined every 10 days. These results suggest that increased HbAI levels may be reversed early by strict blood glucose control during a 3 day period. It is concluded that HbAI levels not only reflect long-term glycaemic control, but also recent acute variations in mean blood glucose values.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00290488
Permalink